Post-Hoc: Lilly gets more secretive and hides Phase 1 pipeline

May 29, 2026 01:23 PM EDTUpdated 19 hours ago R&DPharma Post-Hoc: The world's biggest drug­mak­er gets more se­cre­tive Drew Armstrong Executive Editor Eli Lil­ly is get­ting more opaque as it gets big­ger. Ear­li­er this year, the drug­mak­er stopped dis­clos­ing its ear­ly-stage pipeline work. Its Phase 1 projects … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER